Feasibility study of short hydration using oral rehydration solution in cisplatin including chemotherapy of lung cancer

BACKGROUND: Cisplatin (CDDP) is used as a key anticancer drug for solid cancers, including lung cancer. However, a large quantity of fluid replacement is required to prevent renal dysfunction. This requirement have made outpatient chemotherapies including CDDP administration less popular among the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Junya, Morikawa, Naoto, Nitanai, Hiroo, Nagashima, Hiromi, Nihei, Satoru, Yamauti, Kohei, Kudo, Kenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779197/
https://www.ncbi.nlm.nih.gov/pubmed/26949541
http://dx.doi.org/10.1186/s40780-016-0041-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779197/
https://www.ncbi.nlm.nih.gov/pubmed/26949541
http://dx.doi.org/10.1186/s40780-016-0041-z

Ejemplares similares